Lance A. Liotta MD PhD is CoDirector and CoFounder of the Center for Applied Proteomics and Molecular Medicine at George Mason University, where he is also Medical Director of the Clinical Proteomics Laboratory. Prior to this position he was Chief of the Laboratory of Pathology and Deputy Director of NIH, NCI.  Dr. Liotta has devoted his career to the study of tumor invasion and metastasis and the creation of technology for molecular analysis of tissue and body fluids. This technology includes Laser Capture Microdissection, Reverse Phase Protein Microarrays, Biomarker Harvesting Hydrogel Nanoparticles, and Molecular Preservatives for Phosphoprotein Preservation. These technologies are used in ongoing clinical research trials aimed at the discovery of markers for early stage disease, individualized therapy for metastatic cancer, and adjuvant therapy of premalignant breast cancer.